Intervention not reported
Serious adverse events · People with multiple sclerosis
1 finding from 1 review
Serious adverse events · patients with acute pancreatitis
It is very uncertain whether probiotics changes serious adverse events compared with control (very low certainty).
1 finding from 1 review
Serious adverse events · School‐aged children and adults
Intermittent ICS showed no clear difference in serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · Preschool children (<6 years)
Intermittent ICS showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · Adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Serious adverse events · patients with induction of remission in ulcerative colitis
Etrolizumab showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · Patients with fibromyalgia
It is very uncertain whether the intervention changes serious adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · adults with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serious Adverse Events · patients with rheumatoid arthritis
The intervention showed no clear difference in serious Adverse Events (moderate certainty).
1 finding from 1 review
Serious adverse events · patients with chronic asthma
LABA + ICS showed no clear difference in serious adverse events compared with LTRA + ICS (moderate certainty).
1 finding from 1 review
Serious adverse events · patients with osteoarthritis of the knee
Other types of high tibial osteotomy (aHTO) showed no clear difference in serious adverse events compared with closing wedge high tibial osteotomy (CW‐HTO) (low certainty).
1 finding from 1 review
Serious adverse events · Patients with ankylosing spondylitis
Sulfasalazine showed no clear difference in serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · adults with neuropathic pain (Trigeminal neuralgia, painful diabetic neuropathy, chronic post stroke pain)
1 finding from 1 review
Serious adverse events · patients with osteoporosis
1 finding from 1 review
Serious adverse events · patients with osteoporosis
1 finding from 1 review
Serious adverse events · patients with osteoporosis
1 finding from 1 review
Serious adverse events · patients with osteoporosis
1 finding from 1 review
Intervention not reported
Reported adverse events · people with stroke or transient ischaemic attack
The intervention showed no clear difference in reported adverse events (low certainty).
1 finding from 1 review
Adverse events (1 year) · participants (> 30 years) with cataract and presbyopia
1 finding from 1 review
Serious adverse eventsd · adults with low back pain
1 finding from 1 review